Factors affecting relapse rate in patients with neuromyelitis optica spectrum disorder

Lancet Neurol. 2020 Jul;19(7):564. doi: 10.1016/S1474-4422(20)30184-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aquaporin 4
  • Double-Blind Method
  • Humans
  • Neuromyelitis Optica*
  • Recurrence
  • Rituximab

Substances

  • Aquaporin 4
  • Rituximab